{"id":"prophylactic-platelet-transfusion","safety":{"commonSideEffects":[{"rate":"null","effect":"Febrile non-hemolytic transfusion reaction"}]},"_chembl":{"chemblId":"CHEMBL2108774","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This treatment aims to increase the number of platelets in the blood to prevent bleeding complications. Platelet transfusions are typically used in patients with thrombocytopenia, a condition characterized by low platelet counts. The transfused platelets help to form blood clots and prevent excessive bleeding.","oneSentence":"Prophylactic platelet transfusion involves administering platelets to prevent bleeding in patients with low platelet counts.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:30:25.254Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of bleeding in patients with thrombocytopenia"}]},"trialDetails":[{"nctId":"NCT06605144","phase":"PHASE3","title":"Canadian Critical Care Comparative Effectiveness Platform","status":"RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2025-03-23","conditions":"Intensive Care Unit ICU, Vasopressor, Platelet","enrollment":5500},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT04448184","phase":"PHASE3","title":"Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2022-02-16","conditions":"Hematologic Neoplasms","enrollment":662},{"nctId":"NCT07235436","phase":"","title":"Platelet Cryopreservation","status":"COMPLETED","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2020-12-31","conditions":"Platelet Cryopreservation","enrollment":10},{"nctId":"NCT06043050","phase":"","title":"PRedicting OutcomeS in Preterm nEonates With thromboCyTopenia","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2022-09-26","conditions":"Neonatal Thrombocytopenia, Intraventricular Hemorrhage, Platelet Transfusion","enrollment":1042},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT05667805","phase":"PHASE4","title":"Coagulation in Cirrhosis","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2023-01-19","conditions":"Liver Cirrhosis","enrollment":400},{"nctId":"NCT05734001","phase":"NA","title":"Rotational Thromboelastometry Versus Conventional Haemostatic Tests in Children With Decompensated Cirrhosis Undergoing Invasive Procedures.","status":"RECRUITING","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2022-11-18","conditions":"Decompensated Cirrhosis","enrollment":90},{"nctId":"NCT02074436","phase":"PHASE2","title":"PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)","status":"TERMINATED","sponsor":"Emory University","startDate":"2014-05-23","conditions":"Hematological Malignancies, Thrombocytopenia","enrollment":29},{"nctId":"NCT04460222","phase":"NA","title":"Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2020-11-16","conditions":"Cirrhosis, Liver","enrollment":60},{"nctId":"NCT03391856","phase":"PHASE2, PHASE3","title":"Prolonged Isolated Thrombocytopenia After Allo-SCT : N-acetyl-L-cysteine (NAC) Versus Supportive Therapy","status":"TERMINATED","sponsor":"Peking University People's Hospital","startDate":"2018-03-01","conditions":"Thrombocytopenia, Stem Cell Transplant Complications","enrollment":15},{"nctId":"NCT03288441","phase":"","title":"Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia","status":"UNKNOWN","sponsor":"Maastricht University Medical Center","startDate":"2018-03-20","conditions":"Hematologic Neoplasms, Thrombocytopenia, Anticoagulants","enrollment":300},{"nctId":"NCT02650791","phase":"PHASE3","title":"Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study","status":"COMPLETED","sponsor":"Ottawa Hospital Research Institute","startDate":"2016-10","conditions":"Hematologic Neoplasms","enrollment":100},{"nctId":"NCT00745797","phase":"PHASE3","title":"Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy","status":"TERMINATED","sponsor":"Yi-Long Wu","startDate":"2008-04","conditions":"Brain Metastases","enrollment":5},{"nctId":"NCT02906878","phase":"","title":"Platelet Kinetics After Platelet Transfusion for the Placement of a Central Venous Catheter","status":"UNKNOWN","sponsor":"University Hospital, Angers","startDate":"2016-06","conditions":"Thrombopenia, Central Venous Catheter Placement","enrollment":30},{"nctId":"NCT00128713","phase":"PHASE3","title":"Optimal Platelet Dose Strategy for Management of Thrombocytopenia","status":"COMPLETED","sponsor":"Carelon Research","startDate":"2004-07","conditions":"Thrombocytopenia","enrollment":1351},{"nctId":"NCT01615146","phase":"NA","title":"Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot","status":"TERMINATED","sponsor":"Ottawa Hospital Research Institute","startDate":"2012-06","conditions":"Myelodysplastic Syndrome, Leukemia","enrollment":9},{"nctId":"NCT00577096","phase":"NA","title":"Effects of Exercise in Combination With Epoetin Alfa","status":"COMPLETED","sponsor":"University of Arkansas","startDate":"2001-10","conditions":"Multiple Myeloma","enrollment":120},{"nctId":"NCT00521664","phase":"PHASE3","title":"A Trial Comparing a Prophylactic With a Therapeutic Platelet Transfusion Strategy in Two Groups","status":"COMPLETED","sponsor":"Technische Universität Dresden","startDate":"2004-09","conditions":"Myeloid Leukemia","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":207,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Prophylactic platelet transfusion","genericName":"Prophylactic platelet transfusion","companyName":"Technische Universität Dresden","companyId":"technische-universit-t-dresden","modality":"Biologic","firstApprovalDate":"","aiSummary":"Prophylactic platelet transfusion involves administering platelets to prevent bleeding in patients with low platelet counts. Used for Prevention of bleeding in patients with thrombocytopenia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}